Clinical trial
Reversibility of Propylene Glycol/Glycerol Intake Effects on Cardiorespiratory Function
NCT03410511 is registered in ClinicalTrials.gov with Université Libre de Bruxelles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reversibility of Propylene Glycol/Glycerol Intake Effects on Cardiorespiratory Function
- Lead sponsor
- Université Libre de Bruxelles
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 15, 2018
- Completion date
- June 30, 2020
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.